FAS1A - Overview: Anti-SAE1 Ab, IgG
Anti-SAE1 Ab, IgG
FACN1 - Overview: Anti-cN-1A (NT5c1A) IBM
Anti-cN-1A (NT5c1A) IBM
FFRFT - Overview: Anti-Synthetase Profile
Anti-Synthetase Profile
FAPIX - Overview: Apixaban, Plasma
Apixaban, Plasma
FAMBT - Overview: Amyloid Beta-Protein
Amyloid Beta-Protein
FBROM - Overview: Bromine - Total, Blood
Bromine - Total, Blood
FCBDS - Overview: Cannabidiol, Serum
Cannabidiol, Serum
FCOKE - Overview: Cocaine Analysis - Whole Blood
Cocaine Analysis - Whole Blood
FMARI - Overview: Cannabinoid Analysis, Whole Blood
Cannabinoid Analysis, Whole Blood
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...